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CURRENT LEGISLATION
CONTROL OF THE SALE OF SLEEPING PILLS.-Since barbiturates
were first prepared in 1903 by the German Nobel Prize winner, Emil
Fischer, more than 1,500 derivatives of barbituric acid have been
discovered. These drugs have proved of the utmost value to the
medical profession, especially useful in the treatment of neurotic ills.'
During recent times, particularly during the war years, many persons
have come to rely upon the barbiturates in the form of sleeping pills to
provide untroubled sleep for minds besieged with worries. The
ease with which these pills could be obtained made them an ever-
popular home remedy for the treatment of "war-nerves" and
insomnia.
Recent investigations have revealed an alarming increase in the
use of barbiturates 2 as well as a surprisingly large number of in-
stances where the undesirable effects of the drug have outweighed its
medicinal value.3 Disclosures point to the fact that these sleeping
pills are frequently a factor in delinquency, 4 the commission of crimes,
suicides and accidental deaths.5 Medical reports have stressed the
fact that the barbiturates are potentially habit-forming, 6 that they
have a cumulative toxic effect upon the body, and have been known
to cause serious mental disorders when taken over an extended period
without proper medical supervision. In addition, an extensive
"black-market" in barbiturates has appeared on the scene catering
principally to the narcotic addict who has found it increasingly diffi-
cult to obtain his usual supply of "dope". 7
These revelations have caused medical groups and public health
committees in numerous localities to demand stricter measures of
control over the sale and distribution of these drugs.8 The problem
of enacting legislation which will adequately meet this rising menace
and yet not interfere with the freedom of the physician in his practice
has become the responsibility of legislative bodies throughout the
:'PHYSIOLOGICAL REVIEWS, Oct. 1939, p. 472.
2 It has been estimated that more than a billion and a half grains of
barbiturates are consumed annually in the United States. HYGErA, June 1945.
3 CONN. MED. J., Feb. 1942: "Report of study made by Society's Com-
mittee on Drug Addiction."
4 N. Y. Times, Feb. 3, 1944, p. 36, col. 7.
5. "The national incident of suicide by means of the barbiturates in large
cities averages up to 16 per cent of all poisons except gases." PA. MEn. J.,
Feb. 1944, p. 451. Also see JouRNAL OF THE AmxEIcAN MEDIcAL Assoc.,
April 8, 1939, p. 1340.6 AN STHESSIOWGY, May 1943, p. 238.
7N. Y. Times, July 24, 1945, p. 25, col. 5.8 JouRNAL 'oF MEDiciNE, Feb. 1940, p. 12: "Symposium of Barbituric
Acid."
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country. Because of the medical aspects of the problem many medi-
cal associations have conducted their own investigations and sub-
mitted their own reports and recommendations to the various
legislatures.9
As an answer to the general clamor for the enactment of legis-
lation of this type, the New York State Legislature has enacted Sec-
tion 1366-a of the Education Law.'0 The effect of this law is to
prohibit the dispensing of barbital and other hypnotic and somni-
facient drugs except by those persons authorized by law to do so
and, further, to prevent the sale of these drugs except to persons who
are taking them upon the advice of a physician, as evidenced by a
prescription. The law also makes provisions for the recording of
all sales made by the retail dispenser of the drugs.
It must be noted that the drugs covered by this law are for the
most part not included within -the term "narcotic drug" as defined in
the Public Health Law," nor are they covered by the provisions of
the Federal Narcotic Laws.' 2
The provisions of Section 1366-a are as follows:
1. No barbital or other hypnotic or somnifacient drug may be
sold except on the prescription of one authorized to issue same.
2. The prescription must be compounded by a licensed pharma-
cist or druggist.
3. The dispenser must affix to the container a label containing:
a. The name and address of the owner of the establishment
dispensing same.
9 Tentative report of the Committee on Public Health Relations of the
New York Academy of Medicine, Nov. 19, 1945.
'ON. Y. Laws 1945, c. 664, effective April 10, 1945. A similar provision,
§ 1060-a of former Article 51, was added by Laws 1939, c. 778, and repealed
by the general revision of Article 51 by Laws 1939, c. 869.11 
"It is a matter of common knowledge that there are certain substances
which would be classified as narcotic under the dictionary definition, but would
not be included within the term 'narcotic drug' as defined in the Public Health
Law." People v. Lee Foon, 294 N. Y. Supp. 872 (1937).
Public Health Law § 421 defines narcotic drug "as coca leaves, opium,
cannabis and every substance neither chemically nor physically distinguishable
from them."
Article 22 of the Public Health Law is known as the "Uniform Narcotic
Drug Act." § 420, added by Laws 1933, c. 684. "The purpose of this article
is to parallel and supplement federal narcotic laws." People v. Gennaro, 261
App. Div. 533 (1941), aff'd, 39 N. E. (2d) 283 (1942).
Corpus Juris defines narcotic as "a medicine which in medicinal doses re-
lieves pain and produces sleep, but which in poisonous doses produces stupor,
coma or convulsions, and when given in sufficient quantity produces death."
45 C. J. 391. 1
12 26 U. S. C. A. §§ 2550-2606, commonly known as the HAumsox ANTI-
NARoDric AcT.
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b. The date compounded and the file number of the pre-
scription.
c. The name of the person issuing the prescription.
d. Directions for use of the drug as contained in the pre-
scription.
4. Where the prescription provides that it is not to be renewed
or refilled the pharmacist may not do so.
5. Duplicate prescriptions may not be issued.
The term "barbital" as used in the section includes salts of bar-
bituric acid, also known as malonyl urea, or any derivatives or com-
pounds of any preparations or mixtures thereof possessing hypnotic
properties or effects.
The term "other hypnotic or somnifacient drugs" includes
suphonal, trional, tetronal, cabromal or any derivatives or compounds
or preparations or mixtures thereof, and chloral or chloral hydrate
or chlorobutanor or any mixtures or preparations thereof to be used
internally.
The Act does not apply to a person "duly authorized to use
hypnotic and somnifacient drugs in connection with his practice,"
but such a person is required to keep "a record of the date, the drug
and the quantity thereof dispensed and the name and address of the
patient."
Further, the Act does not apply to any preparation to be used
as a spray, gargle or liniment or for external application provided
such preparation contains some other drug or drugs "rendering it
unfit for internal administration," and provided that such preparation
is not sold for the purpose of evading the provisions of the Act.
It does not require a very close inspection of the new law to
discover its many weaknesses and loopholes. In the first place the
Act is designed to cover the dispensing of the specified drugs by the
pharmacist or druggist only. It does not apply to the distribution of
the drugs by the manufacturer or wholesaler, nor are such persons
required to keep records of sales and purchases. Consequently, it
does not prevent the drug from being diverted from legitimate medi-
cal and pharmaceutical channels into illicit traffic. Further, the new
law permits a prescription, once obtained, to be refilled without limit
unless otherwise provided in the prescription and also fails to limit
the quantity of the drug that may be procured on a single prescrip-
tion. Thus, it does not adequately safeguard against the practice of
passing on the empty container to a friend who may have the same
refilled when the patient no longer has need of the drug. Although
a blanket prohibition on refilling prescriptions has been almost unani-
mously opposed by medical and pharmaceutical associations on the
ground that it would be an undue financial burden upon many pa-
tients to require them to return to the physician every time their
supply of pills became exhausted, nevertheless, most groups advocate
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the placing of an expiration date on each prescription so that it could
not be refilled indefinitely. The practice of permitting the patient to
obtain a large supply of barbiturates on one prescription has likewise
been disapproved. It is felt that such a practice might provide the
"black-market" with an easy source of supply.
It is undoubtedly true that the many weaknesses and loopholes
in Section 1366-a will have to be eliminated before it can accomplish
its purpose of minimizing the dangers of the widespread use of sleep-
ing pills.18 In New York City, where provisions similar to those
of Section 1366-a have long been contained in the Sanitary Code,' 4
the situation today is no less threatening than in jurisdictions where
no restrictions whatever are enforced.15 It is the general opinion
that enforcement of existing provisions is insufficient and that stricter
regulations are necessary.1
The enactment of Section 1366-a is apparently only the first step
towards strict state control of these dangerous drugs. It does not
seem entirely remote that subsequent legislative action on this sub-
ject will eventually result in classifying barbital and other hypnotic
and somnifacient drugs as "narcotic drugs," hence bringing them
within the stricter provisions of the Public Health Law,'7 a solution
that has been strongly advocated and one that has already been
enacted in some jurisdictions.' 8
CHARLES E. WALDRON.
S13State Senator Thomas C. Desmond of Newburgh is at present drafting
a bill shortly to be introduced in the Senate. Mr. Desmond proposes addi-
tional provisions among which are: 1. Possession of the drug by any person
other than the one named in the prescription would be illegal. 2. Prescriptions
not refillable. 3. Manufacturers and wholesalers would be required to keep
records of sales and purchases.
The Board of Health of the City of New York at a meeting held on
December 11, 1945 urged the adoption of measures similar to those advocated
by Senator Desmond.
1 4 SAmTARY CoDn §§ 117(2), 118.
The Sanitary Code was formulated by the Board of Health of the City
of New York pursuant to authority conferred by § 558 of the New York City
Charter.
The Charter has long provided that any violation of the Sanitary Code
shall be treated and punished as a misdemeanor. People v. Blanchard, 228
N. Y. 145 (1942).15 In 1944 there were five times as many deaths caused by sleeping pills
in New York City than were recorded in 1937. Busnzss WEK, March 24,
1945, p. 88.
16 Letter, Commissioner of Health, City of New York, Dec. 17, 1945, and
end.
17 PENAL LAw § 1751 provides that violations of Article 22 of the Public
Health Law (Uniform Narcotic Drug Act) may be punished as felonies.
38 Vermont Public Laws § 5371 classifies barbital as a narcotic drug and
prohibits the refilling of a prescription unless authorized by the prescribing
physician.
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